Dr. Alessandro Santin
Claim this profileSmilow Cancer Hospital at Yale New Haven
Studies Ovarian Cancer
Studies Endometrial Cancer
17 reported clinical trials
25 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
FRα positive
Stage III
2Endometrial Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Alessandro Santin is currently running
Avutometinib + Defactinib
for Ovarian Cancer
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progressed on a prior platinum-based therapy.
Recruiting2 awards Phase 38 criteria
Sacituzumab Govitecan
for Endometrial Cancer
This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.
Recruiting1 award Phase 220 criteria
More about Alessandro Santin
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Alessandro Santin has experience with
- Carboplatin
- Paclitaxel
- Sacituzumab Govitecan
- Pembrolizumab
- Defactinib
- Topotecan
Breakdown of trials Alessandro Santin has run
Ovarian Cancer
Endometrial Cancer
Skin Cancer
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alessandro Santin specialize in?
Alessandro Santin focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are FRα positive.
Is Alessandro Santin currently recruiting for clinical trials?
Yes, Alessandro Santin is currently recruiting for 7 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Alessandro Santin has studied deeply?
Yes, Alessandro Santin has studied treatments such as Carboplatin, Paclitaxel, Sacituzumab Govitecan.
What is the best way to schedule an appointment with Alessandro Santin?
Apply for one of the trials that Alessandro Santin is conducting.
What is the office address of Alessandro Santin?
The office of Alessandro Santin is located at: Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut 06510 United States. This is the address for their practice at the Smilow Cancer Hospital at Yale New Haven.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.